Back to Search
Start Over
Efficacy and safety of durvalumab with olaparib in metastatic or recurrent endometrial cancer (phase II DOMEC trial)
- Authors :
- MS Radiotherapie
MS Medische Oncologie
Cancer
Post, C C B
Westermann, A M
Boere, I A
Witteveen, P O
Ottevanger, P B
Sonke, G S
Lalisang, R I
Putter, H
Meershoek-Klein Kranenbarg, E
Braak, J P B M
Creutzberg, C L
Bosse, T
Kroep, J R
MS Radiotherapie
MS Medische Oncologie
Cancer
Post, C C B
Westermann, A M
Boere, I A
Witteveen, P O
Ottevanger, P B
Sonke, G S
Lalisang, R I
Putter, H
Meershoek-Klein Kranenbarg, E
Braak, J P B M
Creutzberg, C L
Bosse, T
Kroep, J R
- Publication Year :
- 2022
Details
- Database :
- OAIster
- Notes :
- English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1432118781
- Document Type :
- Electronic Resource